1. Spain Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
Laboratorios Farmaceuticos Rovi, S.A.

Laboratorios Farmaceuticos Rovi, S.A.

ROVI.MC
Laboratorios Farmaceuticos Rovi, S.A.ES flagMadrid Stock Exchange
57.55
EUR
-0.30
- -
2.94BMarket Cap
2012 Y
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
TTM
Revenue per Share
4.07
4.37
4.78
4.97
5.38
5.59
5.92
6.91
7.58
11.71
15.29
16.01
14.93
18.76
Basic EPS, GAAP
0.39
0.46
0.48
0.4
0.53
0.35
0.35
0.71
1.1
2.76
3.73
3.29
2.68
3.72
Free Cash Flow per Basic Share
0.12
0.1
-0.04
0.19
0.56
-0.04
-0.35
-0.9
0.13
1.96
3.48
1.12
1.49
2.11
Dividend per Share
0.13
0.14
0.16
0.17
0.14
0.18
0.12
0.08
0.18
0.38
0.95
1.33
1.1
- -
Book Value per Share
2.58
2.91
3.23
3.48
3.88
4.05
4.06
4.43
5.52
8.1
8.59
10.78
9.57
10.53
Tangible Book Value per Share
2.48
2.61
2.84
2.95
3.22
3.34
4.94
5.03
6
7.8
9.08
9.83
10.71
11.68
Basic Weighted Avg Shares
50
50
50
50
49
49
51
55
55
55
53
52
51
51
Sales/Revenue/Turnover
202
218
238
246
265
276
303
381
420
649
818
830
764
959
Operating Margin (%)
10.74
11.71
11.63
8.88
10.67
6.9
5.76
11.33
18.44
27.98
31.29
26.55
23.51
26.09
Depreciation Expense
5
7
9
10
11
11
12
18
20
21
23
24
28
30
Net Income, GAAP
20
23
24
20
26
17
18
39
61
153
200
170
137
190
Effective Tax Rate (%)
6.35
5.07
5.92
5.21
6.43
1.6
- -
6.22
15.88
16.18
22.6
22.73
22.97
22.94
Profit Margin (%)
9.66
10.58
10.13
8.05
9.84
6.25
5.9
10.3
14.54
23.6
24.42
20.53
17.92
19.83
Working Capital
76
79
100
95
91
95
166
211
242
316
329
309
333
374
LT Debt
29
23
32
33
21
27
17
72
68
67
59
52
91
97
Total Equity
126
144
158
165
183
192
287
322
374
471
521
543
582
633
Return on Invested Capital (%)
12.32
14.21
14.07
10.29
12.47
8.27
- -
11.11
15.25
30.67
34.79
28.18
21.07
25.84
Return on Capital (%)
12.97
14.27
14.09
10.43
12.24
7.79
- -
13.96
17.43
34.1
37.95
29.44
22.3
30.26
Return on Common Equity (%)
16.04
16.86
15.78
11.9
14.34
8.82
8.78
17.36
22.2
40.58
43.98
33.46
26.12
37.86

Capital Structure

FRC

•

in mil. unless spec.
Mar'25
Jun'25
Sep'25
ST Debt
23
28
26
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
51
51
51
Market Capitalization
2,633
2,800
2,974

Working Capital

FRC

•

in mil. unless spec.
Mar'25
Jun'25
Sep'25
Total Current Assets
468
516
559
Cash, Cash Equivalents & STI
29
48
49
Accounts Receivable, Net
116
136
191
Inventories
319
328
315
Total Current Liabilities
126
187
185
Payables & Accruals
- -
- -
- -
ST Debt
23
28
26
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
14.58%
12.78%
7%
Free Cash Flow
186.7%
265.92%
31%
Net Income, GAAP
30.55%
40.46%
-19.64%
Sales/Revenue/Turnover
13.5%
16.83%
-7.93%
Total Cash Common Dividend
35.36%
79.16%
-18.25%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
151
178
235
434
764
2025
155
160
210
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.29
- -
- -
1.81
2.68
2025
0.35
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
1.1
2025
- -
- -
- -
- -
- -

Company Description

APIChat
CEO
Juan Lopez-Belmonte Encina
Full Time Employees
2,197
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Address
Calle José Isbert, 2 Madrid Spain 28223
IPO Date
Dec 5, 2007
Website
rovi.es
Similar Companies
Chalice Brands Ltd. (CHAL.CN)
Shenzhen Neptunus Interlong Bio-technique Company Limited (8329.HK)
Hunan Hansen Pharmaceutical Co., Ltd. (002412.SZ)
Apimeds Pharmaceuticals US, Inc (APUS)
Hainan Haiyao Co., Ltd. (000566.SZ)
Greenrise Global Brands Inc. (XCX.CN)
Business